Publicación:
Rol de los receptores nicotínicos de acetilcolina en mecanismos de dolor

dc.contributor.authorJérez Escobar, Javierspa
dc.contributor.authorMartínez Visbal, Alfonsospa
dc.date.accessioned2020-11-27 00:00:00
dc.date.available2020-11-27 00:00:00
dc.date.issued2020-11-27
dc.format.mimetypeapplication/pdfspa
dc.identifier.doi10.32997/rcb-2015-2990
dc.identifier.eissn2389-7252
dc.identifier.issn2215-7840
dc.identifier.urihttps://hdl.handle.net/11227/13272
dc.identifier.urlhttps://doi.org/10.32997/rcb-2015-2990
dc.language.isospaspa
dc.publisherUniversidad de Cartagenaspa
dc.relation.bitstreamhttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/2990/2523
dc.relation.citationeditionNúm. 1 , Año 2015spa
dc.relation.citationendpage129
dc.relation.citationissue1spa
dc.relation.citationstartpage118
dc.relation.citationvolume6spa
dc.relation.ispartofjournalRevista Ciencias Biomédicasspa
dc.relation.referencesUmana I, Daniele C, McGehee D. Neuronal nicotinic receptors as analgesic targets: It’s a winding road. Biochemical Pharmacology. 2013;86:1208-14.spa
dc.relation.referencesBrandt D. The cigarette century: the rise, fall and deadly persistence of the product that defined America. J of Popular Culture. 2008;(41)5:893-4.spa
dc.relation.referencesCorti C. A history of smoking. London: George C. Harrap. 2007.spa
dc.relation.referencesHurts R, Rollema H, Bertrand D. Nicotinic acetylcholine receptors: From basic science to therapeutics. Pharmacology & Therapeutics 2013;137(2):22-54.spa
dc.relation.referencesDavis L, Pollock LJ, Stone T. Visceral pain. Surgery Gynecology and Obstetrics 1932;55(2):418-27. 6. Criado M. El receptor nicotínico de acetilcolina. Instituto de Neurociencias, Sant Joan d’Alacant, Alicante, España. 2011.spa
dc.relation.referencesFlores M, Segura J. Estructura y función de los receptores acetilcolina de tipo muscarínico y nicotínico. Rev Mex Neuroci 2005;6(4):315-26.spa
dc.relation.referencesDíaz M, Gualix J, Gómez R, Castro R, Pintor J, Miras Portugal MT. Receptores nicotínicos neurales: interacción con receptores purinérgicos. Anal Real Acad Farm. 2000; 66(1):1-21.spa
dc.relation.referencesDevillers-Thiéry A, Galzi JL, Eiselé JL, Bertrand S, Changeux JP. Functional architecture of the nicotinic acetylcholine receptor: a prototype of ligand-gated ion channels. J. Membr. Biol. 1993;136:97-112.spa
dc.relation.referencesKarlin, A. and Akabas, M. H. Toward a structural basis for the function of nicolinic acetylcholine receptors and their cousins. Neuron. 1995;15:1231-44.spa
dc.relation.referencesPaterson D, Nordberg A. Neuronal nicotinic receptors in the human brain. Progress in Neurobiology. 2000;61:75-111. Gotti C, Fornasari D, Clementi F. Human neuronal nicotinic receptors. Prog Neurobiol. 1997;53:199-37.spa
dc.relation.referencesSargent PB. The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 1993;16:403-43.spa
dc.relation.referencesElgoyhen A B, Johnson DS, Boulter J, Vetter DE, Heinemann S. α9: An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell. 1994;79:705-15.spa
dc.relation.referencesGalzi JL, Changeux JP. Neuronal nicotinic receptors: molecular organization and regulations. Neuropharmacology.1995;34:563-82.spa
dc.relation.referencesLuetje CW, PatrJck J. Both OE- and /J-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J Neurosci. 1991;11: 837-45.spa
dc.relation.referencesLevin ED, Simon BB. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology. 1998;138:217-30.spa
dc.relation.referencesCartaud J, Benedetti E.L, Cohen J.B, Meunier J.C, Changeux J.P. Presence of a lattice structure in membrane fragments rich in nicotinic receptor protein from the electric organ of Torpedo marmorata. FEBS Lett. 1973;33:109-13.spa
dc.relation.referencesSargent P.B. The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci. 1993;16:403-43.spa
dc.relation.referencesHogg RC, Bertrand D. Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors. Biochem Pharmacol. 2007;73:459-68.spa
dc.relation.referencesIwamoto ET. Characterization of the antinociception induced by nicotine in the pedunculopontine tegmental nucleus and the nucleus raphe magnus. J Pharmacol Exp Ther. 1991;257:120-33.spa
dc.relation.referencesConroy WG, Vernallis AB, Berg DK. The alpha 5 gene product assembles with multiple acetylcholine receptor subunits to form distinctive receptor subtypes in brain. Neuron. 1992;9:679-91.spa
dc.relation.referencesCouturier S, Bertrand D, Matter J.M, Hernandez M.C, Bertrand S, Millar N, Valera S, Barkas T, Ballivet M. A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX. Neuron. 1990;5:847-56.spa
dc.relation.referencesBallantyne JC, Shin NS. Efficacy of opioids for chronic pain: a review of the evidence. Clinical J of Pain. 2008;24:469-78.spa
dc.relation.referencesHamann SR, Martin WR. Opioid and nicotinic analgesic and hyperalgesic loci in the rat brain stem. J of Pharmacology and Experimental Therapeutics. 1992; 261:707-15.spa
dc.relation.referencesSahley TL, Berntson GG. Antinociceptive effects of central and systemic administrations of nicotine in the rat. Psychopharmacology. 1979;65:279-83.spa
dc.relation.referencesFertig JB, Pomerleau OF, Sanders B. Nicotine-produced antinociception in minimally deprived smokers and ex-smokers. Addictive Behaviors. 1986;11: 239-48.spa
dc.relation.referencesHenningfield JE, Miyasato K, Jasinski DR. Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J of Pharmacology and Experimental Therapeutics. 1985;234:1-12.spa
dc.relation.referencesKottke TE, Brekke ML, Solberg LI, Hughes JR. A randomized trial to increase smoking intervention by physicians. Doctors helping smokers, Round I. JAMA 1989;261:2101-6.spa
dc.relation.referencesCepeda-Benito A, Reynoso J, McDaniel EH. Associative tolerance to nicotine analgesia in the rat: tail-flick and hot-plate tests. Experimental and Clinical Psychopharmacology. 1998; 6(2):248-54.spa
dc.relation.referencesHogg R.C, Raggenbass M, Bertrand D. Nicotinic acetylcholine receptors: from structure to brain function. Rev. Physiol. Biochem. Pharmacol. 2003;147:1-46.spa
dc.relation.referencesMarubio L.M, del Mar Arroyo-Jimenez M, Cordero-Erausquin M, Léna C, Le Novère N, de Kerchove d’Exaerde A, Huchet M, Damaj M.I, Changeux J.P. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature. 1999;398(5):805-10.spa
dc.relation.referencesDamaj MI, Fonck C, Marks MJ, Deshpande P, Labarca C, Lester HA, Collins AC, Martin BR. Genetic approaches identify differential roles for α4β2 nicotinic receptors in acute models of antinoniception in mice. J. Pharmacol Exp Ther. 2007;321:1161-9.spa
dc.relation.referencesShi Y, Weingarten TN, Mantilla CB, Hooten WM, Warner DO. Smoking and pain: pathophysiology and clinical implications. Anesthesiology 2010;113:977-92.spa
dc.relation.referencesSher E, Chen Y, Sharples TJ, Broad LM, Benedetti G, Zwart R, McPhie GI, Pearson KH, Baldwinson T, De Filippi G. Physiological roles of neuronal nicotinic receptor subtypes: new insights on the nicotinic modulation of neurotransmitter release, synaptic transmission and plasticity. Curr Top Med. Chem. 2004;4:283-97.spa
dc.relation.referencesNigori R, Jayarajan P, Abraham R, Shanmuganathan D, Rasheed M, Royapalley P, Goura V. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain. European J of Pharmacology. 2011;668:155-62spa
dc.relation.referencesKesingland AC, Gentry CT, Panesar MS, Bowes MA, Vernier JM, Cube R, Walker K, Urban L. Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)- epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain. Pain. 2000;86:113- 18.spa
dc.relation.referencesLynch JJ, Wade CL, Mikusa JP, Decker MW, Honore P. ABT-594 (a nicotinic acetylcholine agonist): antiallodynia in a rat chemotherapy-induced pain model. European J Pharmacol. 2005;509:43-8.spa
dc.relation.referencesGalindo L, Hernández S, Galarraga E, Tapia D, Bargas J, Garduño J, Frías C, Drucker R, Mihailescu S. Serotoninergic dorsal raphe neurons possess functional postsynaptic nicotinic acetylcholine receptors. Synapse. 2008;62: 601-15.spa
dc.relation.referencesNakamura M, Jang S. Presynaptic nicotinic acetylcholine receptors enhance GABAergic synaptic transmission in rat periaqueductal gray neurons. European J of Pharmacology. 2010:640:178-84.spa
dc.relation.referencesBitner R.S, Nikkel A.L, Curzon P, Donnelly-Roberts D.L, Puttfarcken P.S, Namovic M, Jacobs I.C, Meyer M.D, Decker M.W. Reduced nicotinic receptor-mediated antinociception following in vivo antisense knock-down in rat. Brain Res. 2000;871:66-74.spa
dc.relation.referencesCucchiaro G, Chaijale N, Commons K.G. The dorsal raphe nucleus as a site of action of the antinociceptive and behavioral effects of the α4 nicotinic receptor agonist epibatidine. J Pharmacol Exp Ther. 2005;313:389-94.spa
dc.relation.referencesRashid MH, Furue H, Yoshimura M, Ueda H. Tonic inhibitory role of alpha 4 beta 2 subtype of nicotinic acetylcholine receptors on nociceptive transmission in the spinal cord in mice. Pain. 2006;125:125-35.spa
dc.relation.referencesLi X, Eisenach JC. Nicotinic acetylcholine receptor regulation of spinal norepinephrine release. Anesthesiology. 2002;96:1450-56.spa
dc.relation.referencesGenzen R, McGehee D.S. Nicotinic modulation of GABAergic synaptic transmission in the spinal cord dorsal horn. Brain Res. 2005;1031:229-37.spa
dc.relation.referencesMatsunaga K, Klein TW, Friedman H, Yamamoto Y. Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection bynicotine. J Immunol. 2001;167:6518- 24.spa
dc.relation.referencesHosur V, Leppanen S, Abutaha A, Loring R.H. Gene regulation of α4β2 nicotinic receptors: microarray analysis of nicotine-induced receptor up-regulation and anti-inflammatory effects. J Neurochem. 2009;111:848-58.spa
dc.relation.referencesHeinemann S, Boulter J, Deneris E, Conolly J, Duvoisin R, Papke R. The brain nicotinic acetylcholine receptor gene family. Prog Brain Res. 1990;86:195-203.spa
dc.relation.referencesVincler M.A, Eisenach J.C. Immunocytochemical localization of the alpha3, alpha4, alpha5, alpha7, beta2, beta3 and beta4 nicotinic acetylcholine receptor subunits in the locus coeruleus of the rat. Brain Res. 2003;974:25-36.spa
dc.relation.referencesDe Biasi M. Nicotinic receptor mutant mice in the study of autonomic function. Curr. Drug Targets CNS Neurol. Disord. 2002;1:331-36.spa
dc.relation.referencesRamirez-Latorre J, Yu C.R, Qu X, Perin F, Karlin A, Role L. Functional contributions of alpha5 subunit to neuronal acetylcholine receptor channels. Nature. 1996;380:347-51.spa
dc.relation.referencesTapia L, Kuryatov A, Lindstrom J. Ca2+ permeability of the (alpha4)3(beta2)2 stoichiometry greatly exceeds that of (alpha4)2(beta2)3 human acetylcholine receptors. Mol. Pharmacol. 2007;71:769-76.spa
dc.relation.referencesBagdas D, AlSharari S, Freitas K, Tracy M, Imad Damaj M. The role of alpha5 nicotinic acetylcholine receptors in mouse models of chronic inflammatory and neuropathic pain. Biochemical Pharmacology. 2015. doi: 10.1016/j.bcp.2015.04.013.spa
dc.relation.referencesSalas R, Orr-Urtreger A, Broide R.S, Beaudet A, Paylor R, De Biasi M. The nicotinic acetylcholine receptor subunit alpha 5 mediates short-term effects of nicotine in vivo. Mol. Pharmacol. 2003;63:1059-66.spa
dc.relation.referencesJackson KJ, Marks MJ, Vann RE, Chen X, Gamage TF, Warner JA, et al. Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice. Journal of Pharmacology and Experimental Therapeutics. 2010;334:137-46.spa
dc.relation.referencesSalas R, Sturm R, Boulter J, De Biasi M. Nicotinic receptors in the habenulointerpeduncular system are necessary for nicotine withdrawal in mice. J. Neurosci. 2009;29:3014-18.spa
dc.relation.referencesWang N, Orr-Urtreger A, Chapman J, Rabinowitz R, Nachman R, Korczyn A.D. Autonomic function in mice lacking alpha5 neuronal nicotinic acetylcholine receptor subunit. J. Physiol. 2002;542:347-54.spa
dc.relation.referencesVincler M, Eisenach J.C. Plasticity of spinal nicotinic acetylcholine receptors following spinal nerve ligation. Neurosci. Res. 2004;48:139-45.spa
dc.relation.referencesLukas R.J, Changeux J.P, Le Nove` re N, Albuquerque E.X, Balfour D.J, Berg D.K, et al. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev. 1999;51:397-401.spa
dc.relation.referencesShen JX, Yakel JL. Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system. Acta Pharmacol Sin. 2009;30(6):673-80.spa
dc.relation.referencesFeuerbach D, Lingenhoehl K, Olpe H.R, Vassout A, Gentsch C, Chaperon F, Nozulak J, Enz A, Bilbe G, McAllister K, Hoyer D. The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain. Neuropharmacology. 2009;56:254-63.spa
dc.relation.referencesKiguchi , Kobayashi Y, Maeda T, Tominaga S, Nakamura J, Fukazawa Y, Ozaki M, Kishioka S. Activation of nicotinic acetylcholine receptors on bone marrow-derived cells relieves neuropathic pain accompanied by peripheral neuroinflammation. Neurochem Int. 2012;61:1212-19.spa
dc.relation.referencesWestman M, Saha S, Morshed M, Lampa J. Lack of acetylcholine nicotine alpha 7 receptor suppresses development of collagen-induced arthritis and adaptive immunity. Clin Exp Immunol. 2010;162:62-7.spa
dc.relation.referencesFujiwara N, Kobayashi K. Macrophages in inflammation. Curr Drug Targets Inflamm Allergy. 2005;4:281-86.spa
dc.relation.referencesUlloa L. The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov. 2005;4:673-84.spa
dc.relation.referencesDe Rosa MJ, Dionisio L, Agriello E, Bouzat C, Esandi MC. Alpha 7 nicotinic acetylcholine receptor modulates lymphocyte activation. Life Sci. 2009;85:444-49.spa
dc.relation.referencesThomsen MS, Hansen HH, Timmerman DB, Mikkelsen JD. Cognitive improvement by activation of a7 nicotinic acetylcholine receptors: from animal models to human pathophysiology. Curr Pharm Des. 2010;16:323-43.spa
dc.relation.referencesRowley TJ, McKinstry A, Greenidge E, Smith W, Flood P. Antinociceptive and anti-inflammatory effects of choline in a mouse model of postoperative pain. Br J Anaesth. 2010;105(2):201-7.spa
dc.relation.referencesMunro G, Hansen R, Erichsen H, Timmermann D, Christensen J, Hansen H. The alpha7 nicotinic ACh receptor agonist compound B and positive allosteric modulator PNU-120596 both alleviate inflammatory hyperalgesia and cytokine release in the rat. Br J Pharmacol. 2012;167:421-35.spa
dc.relation.referencesMedhurst S.J, Hatcher J.P, Hille C.J, Bingham S, Clayton N.M, Billinton A, Chessell I.P. Activation of the alpha7-nicotinic acetylcholine receptor reverses complete freund adjuvant-induced mechanical hyperalgesia in the rat via a central site of action. J Pain. 2008;9:580-87.spa
dc.relation.referencesXiao HS, Huang QH, Zhang FX, Bao L, Lu YJ, Guo C, Yang L, Huang WJ, Fu G, Xu S.H, et al. Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. Proc Natl Acad Sc. 2002:12;8360-65.spa
dc.relation.referencesGurun MS, Parker R, Eisenach JC, Vincler M. The effect of peripherally administered CDPcholine in an acute inflammatory pain model: the role of alpha7 nicotinic acetylcholine receptor. Anesth Analg. 2009:108;1680-87.spa
dc.relation.referencesFreitas K, Ghosh S, Ivy Carroll F, Lichtman A, Damaj M. Effects of alpha 7 positive allosteric modulators in murine inflammatory and chronic neuropathic pain models. Neuropharmacology. 2013;65:156-64.spa
dc.relation.referencesBertrand D, Gopalakrishnan M. Allosteric modulation of nicotinic acetylcholine receptors. Biochemical Pharmacology. 2007;74:1155-63.spa
dc.relation.referencesFaghih R, Gfesser G.A, Gopalakrishnan M. Advances in the discovery of novel positive allosteric modulators of the alpha7 nicotinic acetylcholine receptor. Recent Pat CNS Drug Discov. 2007;2:99-106.spa
dc.relation.referencesFaghih R, Gopalakrishnan M, Briggs C.A. Allosteric modulators of the alpha7 nicotinic acetylcholine receptor. J Med Chem. 2008;51:701-12.spa
dc.relation.referencesTimmermann DB, Grønlien JH, Kohlhaas KL, Nielsen EØ, Dam E, Jørgensen TD. et al. An allosteric modulator of the a 7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo. J Pharmacol Exp Ther. 2007;323:294-307.spa
dc.relation.referencesGrønlien JH, Håkerud M, Ween H, Thorin-hagene K, Briggs C.A, Gopalakrishnan M, Malysz J. Distinct profiles of a7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes. Mol Pharmacol. 2007;72:715-24.spa
dc.relation.referencesFreitas K, Negus SS, Carroll FI, Damaj MI. In vivo pharmacological interactions between a type II positive allosteric modulator of a7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model. British J of Pharmacology. 2013;169:567-79.spa
dc.relation.referencesGao YJ and Ji RR. Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther. 2010;26:56-68.spa
dc.relation.referencesZhang W, Liu Y, Hou B, Gu X, Ma Z. Activation of spinal alpha-7 nicotinic acetylcholine receptor attenuates remifentanil-induced postoperative hiperalgesia. Int J Clin Exp Med. 2015;8(2):1871- 79.spa
dc.rightsRevista Ciencias Biomédicas - 2020spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/2990spa
dc.subjectReceptores nicotínicosspa
dc.subjectDolorspa
dc.subjectDimensión del dolorspa
dc.subjectClínicas de dolorspa
dc.subjectPercepción del Dolorspa
dc.subjectHiperalgesia.spa
dc.titleRol de los receptores nicotínicos de acetilcolina en mecanismos de dolorspa
dc.title.translatedRol de los receptores nicotínicos de acetilcolina en mecanismos de doloreng
dc.typeArtículo de revistaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.localJournal articleeng
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublication

Archivos

Datos de Contacto

Imagen Escudo Universidad de Cartagena

 

 

 

Línea de Atención

Línea Anticorrupción

Síguenos en: